Skip to main content
Morepen Laboratories Ltd. logo

Morepen Laboratories Ltd. — Investor Relations & Filings

Ticker · MOREPENLAB ISIN · INE083A01026 LEI · 335800OJZDFHFQJ4HP35 BSE.NS Manufacturing
Open in API
Filings indexed 1,661 across all filing types
Latest filing 2019-05-06 Earnings Release
Country IN India
Listing BSE.NS MOREPENLAB

About Morepen Laboratories Ltd.

https://www.morepen.com

Morepen Laboratories Ltd. is a research-led company specializing in the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), home diagnostic devices, and finished formulations. The company maintains a significant global presence, exporting high-quality APIs such as Loratadine, Montelukast, Atorvastatin, and Fexofenadine to numerous international markets. Its diagnostic division, branded as Dr. Morepen, is a prominent player in the home healthcare segment, offering a wide range of products including digital glucometers, blood pressure monitors, and nebulizers. Morepen operates manufacturing facilities compliant with international regulatory standards, including USFDA approvals. The company focuses on leveraging its R&D capabilities to deliver healthcare solutions and maintains a diverse portfolio across various therapeutic areas including cardiovascular, anti-diabetic, and anti-asthmatic treatments.

Recent filings

Filing Released Lang Actions
Please find enclosed the press release on the financial performance of the Company for the Quarter and Year ended 31st March, 2019 with the title - ''Morepen Labs profit rises by 125''Yc, ....
Earnings Release Classification · 95% confidence The document is a press release dated May 6, 2019, announcing the financial performance of Morepen Laboratories Limited for the quarter and year ended March 31, 2019. It includes detailed financial highlights such as revenue, net profit, cash profit, and segment-wise sales growth for Q4 FY 2018-19 and the full fiscal year. The document also discusses the company's debt status and operational highlights. It is addressed to stock exchanges and includes a formal letter format. The content is a detailed earnings announcement with financial results and commentary but does not contain the full comprehensive financial statements or management discussion and analysis typical of an Interim/Quarterly Report (IR) or Annual Report (10-K). It is more than a brief earnings release (ER) as it provides extensive financial data and segment analysis. However, since it is a press release announcing quarterly and annual financial results, it fits best under Earnings Release (ER).
2019-05-06 English
Board of Directors of the Company, in their meeting held on Saturday, 4th May, 2019 (commenced at 12.00 Noon and concluded at 04.00 P.M.), have, inter-alia, considered and approved the ....
Interim / Quarterly Report Classification · 95% confidence The document is a formal communication addressed to stock exchanges (NSE and BSE) regarding the outcome of a Board of Directors meeting. It specifically mentions the approval of the Audited Standalone and Consolidated Financial Results for the quarter and financial year ended 31 March 2019. The document includes detailed financial data such as revenue, expenses, profit before tax, and net profit for the quarter and year ended 31 March 2019. It also references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The presence of detailed audited financial results and auditor's report with unmodified opinion indicates this is a financial results announcement. Given the detailed quarterly and annual financial data, this document fits the definition of an Interim / Quarterly Report (IR) rather than a brief earnings release or just an announcement. The document length (15,000 characters) and inclusion of substantive financial data support this classification.
2019-05-04 English
Financial Result Updates
Regulatory Filings
2019-05-04 English
This is to inform you that the Board of Directors of the Company, in their meeting held on Saturday, 4th May, 2019 (commenced at 12.00 Noon and concluded at 04.00 P.M.), have, inter-alia, ....
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement from Morepen Laboratories Limited addressed to the National Stock Exchange of India and BSE Limited. It reports the outcome of a Board of Directors meeting held on May 4, 2019, where the Board considered and approved the Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2019. The document includes detailed financial data such as revenue, expenditure, profit before tax, and net profit for the specified periods. It also mentions the auditors' report with an unmodified opinion. The presence of comprehensive financial statements and audit report indicates this is a formal financial results announcement. Given the detailed quarterly and annual financial data and the audit report, this document fits the definition of an Interim / Quarterly Report (IR) rather than a brief earnings release or just an announcement of results. The document length (15,000 characters) and content confirm it is a substantive financial report, not merely a notification or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2019-05-04 English
Outcome of Board Meeting
Annual Report Classification · 95% confidence The document is a detailed announcement from Morepen Laboratories Limited addressed to the National Stock Exchange of India and BSE Limited. It reports the outcome of a Board of Directors meeting held on May 4, 2019, where the Board considered and approved the Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2019. The document includes detailed financial tables with revenue, expenses, and profit figures for the quarter and year ended March 31, 2019, and comparative periods. It also mentions the auditors' report with an unmodified opinion. The presence of comprehensive financial data and the approval of audited financial results for a full fiscal year indicate this is a full Annual Report or equivalent financial results announcement. However, since the document is primarily the financial results announcement with auditor's report for the full fiscal year, it aligns with the Annual Report (10-K) category rather than a shorter interim report or just an earnings release. Therefore, the document is best classified as an Annual Report (10-K). FY 2019
2019-05-04 English
Morepen Laboratories Ltd has informed BSE regarding Loss of Share Certificates of the Company
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to stock exchanges (National Stock Exchange of India Ltd. and BSE Limited) regarding the loss of share certificates by shareholders and the request for issuance of duplicate share certificates. It references Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to reporting such events. The content is about notifying the stock exchanges of lost share certificates and related procedural information. There is no financial data, no report attached or referenced as being published, no management discussion, no earnings data, no governance changes, no voting results, no capital changes, and no legal proceedings. This type of document is a regulatory announcement related to compliance and disclosure obligations but does not fit into any of the more specific categories like Annual Report, Earnings Release, or Board changes. It is a regulatory filing informing the exchange of a specific event as required by law. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length is about 5185 characters, which is not extremely short, but the content is clearly an announcement rather than a report or detailed financial document.
2019-05-03 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.